Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity (ACT-OCD)
The Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity: A Randomized Controlled Trial
調査の概要
状態
詳細な説明
This randomized controlled trial investigates the efficacy of an Emotion-Focused Acceptance and Commitment Therapy (ACT) protocol in adults diagnosed with Obsessive-Compulsive Disorder (OCD). Participants will be recruited from the psychiatry outpatient clinic of Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi.
Eligible participants will be randomly assigned to one of two arms:
ACT-based group psychotherapy: Structured group therapy targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification, and committed action. Groups will consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Supportive group psychotherapy (active control): Unstructured supportive group therapy aimed at providing emotional support, enhancing coping with stress, and maintaining current functioning. Groups will consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Assessments will be conducted at baseline and post-treatment using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Dimensional Obsessive-Compulsive Scale (DOCS), Vancouver Obsessional Compulsive Inventory (VOCI), SF-36 Quality of Life Scale, Acceptance and Action Questionnaire-II (AAQ-II), Hospital Anxiety and Depression Scale (HADS), and Toronto Alexithymia Scale (TAS-20).
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Mehmet Emrah Karadere
- 電話番号：05332651664
- メール：memrahkaradere@gmail.com
研究場所
-
-
Istanbul
-
Istanbul、Istanbul、トルコ（Türkiye）、34722
- 募集
- Goztepe Prof. Dr. Suleyman Yalcin City Hospital
-
コンタクト：
- Mehmet Emrah Karadere
- 電話番号：905332651664
- メール：memrahkaradere@gmail.com
-
主任研究者：
- Mehmet Emrah Karadere
-
副調査官：
- Kaasım Fatih Yavuz
-
副調査官：
- Beyza Baran Boz
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria
- Age between 18-65 years
- Minimum literacy level
- Willingness to participate and providing informed consent
Exclusion Criteria:
- Age over 65 years
- Diagnosis of alcohol or substance use disorder
- Comorbid psychotic disorder or intellectual disability
- Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months
- Comorbid psychiatric disorder that would impair group therapy compliance
- History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：ACT-Based Group Psychotherapy
Emotion-focused Acceptance and Commitment Therapy (ACT) based structured group psychotherapy targeting emotional awareness, acceptance, cognitive defusion, present-moment focus, values clarification and committed action.
Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
|
Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action.
Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.
|
|
アクティブコンパレータ：Supportive Group Psychotherapy
Unstructured supportive group psychotherapy aimed at providing emotional support, enhancing coping with stress and maintaining current functioning.
Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
|
Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action.
Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Obsessive-Compulsive Symptom Severity
時間枠：Baseline and 10-12 weeks (post-treatment)
|
Change in OCD symptom severity measured by Yale-Brown Obsessive Compulsive Scale (Y-BOCS) from baseline to post-treatment.
|
Baseline and 10-12 weeks (post-treatment)
|
|
OCD Symtom Severity- DOCS
時間枠：Baseline and 10-12 weeks
|
Change in OCD symptom severity measured by Dimensional Obsessive-Compulsive Scale (DOCS) from baseline to post treatment.
|
Baseline and 10-12 weeks
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Mehmet Emrah Karadere、Goztepe Prof Dr Suleyman Yalcın City Hospital
- 主任研究者：Kaasım Fatih Yavuz、Baglamsal Bilimler ve Psikoterapiler Dernegi
- スタディディレクター：Beyza Baran Boz、Goztepe Prof Dr Suleyman Yalcın City Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2026/0040
- 2025/0040 (その他の識別子：Goztepe SUEH Clinical Research Ethics Committee)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。